Edition:
India

West Pharmaceutical Services Inc (WST.N)

WST.N on New York Stock Exchange

115.90USD
9:39pm IST
Change (% chg)

$0.50 (+0.43%)
Prev Close
$115.40
Open
$115.42
Day's High
$116.01
Day's Low
$115.42
Volume
11,270
Avg. Vol
99,738
52-wk High
$117.72
52-wk Low
$82.79

Latest Key Developments (Source: Significant Developments)

West Chief Financial Officer William Federici Announces Plans To Retire
Friday, 2 Mar 2018 

March 2 (Reuters) - West Pharmaceutical Services Inc ::WEST CHIEF FINANCIAL OFFICER WILLIAM FEDERICI ANNOUNCES PLANS TO RETIRE.WEST PHARMACEUTICAL SERVICES INC - WEST HAS COMMENCED AN EXTERNAL SEARCH FOR A SUCCESSOR TO FEDERICI.  Full Article

West Pharmaceutical Reports Q4 Adjusted Earnings Per Share $0.64
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - West Pharmaceutical Services Inc ::WEST ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS AND ANNOUNCES QUARTERLY DIVIDEND.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.80 TO $2.90.Q4 EARNINGS PER SHARE $0.00.Q4 SALES ROSE 8.7 PERCENT TO $415.6 MILLION.Q4 ADJUSTED EARNINGS PER SHARE $0.64 EXCLUDING ITEMS.SEES FY 2018 SALES $1.72 BILLION TO $1.73 BILLION.BOARD HAS APPROVED A RESTRUCTURING PROGRAM.WEST PHARMACEUTICAL SERVICES - RESTRUCTURING PLAN WILL REQUIRE RESTRUCTURING EXPENSE OF $8.0 MILLION TO $13.0 MILLION.‍COMPANY ESTIMATES ITS 2018 CAPITAL SPENDING WILL BE APPROXIMATELY $150 MILLION​.FOR FULL-YEAR 2017, INCOME TAX EXPENSE WAS $80.9 MILLION, WHICH REPRESENTED AN EFFECTIVE TAX RATE OF 36.4%.Q4 EARNINGS PER SHARE VIEW $0.63, REVENUE VIEW $416.6 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $2.90, REVENUE VIEW $1.73 BILLION -- THOMSON REUTERS I/B/E/S.WEST PHARMACEUTICAL SERVICES - EXPECT RESTRUCTURING WILL PROVIDE CO WITH ANNUALIZED SAVINGS OF $17.0 MILLION TO $22.0 MILLION.  Full Article

West reports Q3 earnings per share of $0.67
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - West Pharmaceutical Services Inc :West announces third-quarter 2017 results.Sees fy 2017 adjusted earnings per share $2.74 to $2.79.Q3 earnings per share $0.67.Q3 sales $398.2 million versus I/B/E/S view $385.9 million.Q3 earnings per share view $0.53 -- Thomson Reuters I/B/E/S.Sees FY 2017 sales $1.595 billion to $1.605 billion.Says ‍hurricanes in Puerto Rico had a negative impact on third-quarter 2017 sales of approximately $2 million​.West Pharmaceutical Services Inc says ‍reaffirmed long-term financial targets​.West Pharmaceutical Services Inc - ‍company estimates its 2017 capital spending to be approximately $150 million​.West Pharmaceutical Services Inc - ‍expects 2018 constant-currency, organic sales growth to be in range of 6% to 8%​.FY2017 earnings per share view $2.67, revenue view $1.59 billion -- Thomson Reuters I/B/E/S.FY2018 revenue view $1.72 billion -- Thomson Reuters I/B/E/S.West Pharmaceutical - at current low levels operations at Puerto Rico , estimate Q4 2017 sales to be adversely impacted by approximately $5 million​.  Full Article

West Pharmaceutical reports Q2 EPS $0.51
Thursday, 27 Jul 2017 

July 27 (Reuters) - West Pharmaceutical Services Inc :West announces second-quarter 2017 results.Sees fy 2017 adjusted earnings per share $2.66 to $2.73.Q2 adjusted earnings per share $0.66.Q2 earnings per share $0.51.Q2 sales $397.6 million versus I/B/E/S view $406 million.Sees FY 2017 sales $1.585 billion to $1.6 billion.Q2 earnings per share view $0.65 -- Thomson Reuters I/B/E/S.Revising full-year 2017 sales and adjusted-diluted EPS guidance.Full-year 2017 sales guidance is expected to be in a range between $1.585 billion and $1.600 billion.Sees FY 2017 consolidated gross profit margin (Pct of net sales) 32.7 pct to 33.3 pct.Sees 2017 capital spending to be up to $150 million, compared to a prior guidance range between $150 million and $175 million.FY2017 earnings per share view $2.73, revenue view $1.61 billion -- Thomson Reuters I/B/E/S.  Full Article

West Pharmaceutical announces increase to quarterly dividend
Thursday, 20 Jul 2017 

July 20 (Reuters) - West Pharmaceutical Services Inc :Sets quarterly dividend of $0.14 per share.West Pharmaceutical Services Inc - Q4 dividend of $0.14 per share, a 7.7 percent increase over $0.13 per share declared for each of four preceding quarters.  Full Article

West Pharmaceutical Q1 EPS $0.81
Thursday, 27 Apr 2017 

April 27 (Reuters) - West Pharmaceutical Services Inc :West announces first-quarter 2017 results.Q1 sales rose 7.1 percent to $387.7 million.Sees fy 2017 earnings per share $2.66 to $2.78.Q1 earnings per share $0.81.Sees fy 2017 sales $1.585 billion to $1.61 billion.West pharmaceutical services inc - reaffirming full-year 2017 sales and raising reported-diluted eps guidance.Fy2017 revenue view $1.60 billion -- Thomson Reuters I/B/E/S.Q1 revenue view $380.4 million -- Thomson Reuters I/B/E/S.  Full Article

West Pharmaceutical Services reports Q4 EPS $0.52
Thursday, 16 Feb 2017 

West Pharmaceutical Services Inc - : Announces fourth-quarter and full-year 2016 results and announces quarterly dividend . Q4 earnings per share $0.52 . Q4 sales $382.3 million versus I/B/E/S view $387.3 million . Q4 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Sees fy 2017 adjusted earnings per share $2.45 to $2.57 . Q4 adjusted earnings per share $0.54 excluding items . Raising guidance for full-year 2017 net sales at constant-currency growth to a range of 7 pct to 9 pct . Sees fy 2017 consolidated net sales $1,585 million to $1,610 million .Estimates its 2017 capital spending to be in range of $150 million to $175 million.  Full Article

West Pharma Q3 adj EPS $0.53; sees FY'16 adj EPS $2.17-$2.22
Thursday, 27 Oct 2016 

West Pharmaceutical Services Inc : West announces third quarter 2016 results . Sees fy 2016 adjusted earnings per share $2.17 to $2.22 . Q3 adjusted earnings per share $0.53 . Q3 earnings per share $0.50 . Q3 sales $376.7 million versus i/b/e/s view $371.3 million . Q3 earnings per share view $0.53 -- Thomson Reuters I/B/E/S . Sees fy 2016 sales $1.51 billion to $1.52 billion . West pharmaceutical services inc- raising full-year 2016 net sales guidance and tightening adjusted diluted eps guidance range . West pharmaceutical services inc- full-year 2016 adjusted diluted EPS is now expected to be between $2.17 and $2.22 . West pharmaceutical services inc- company expects 2017 organic sales growth to grow at high end of its long-term outlook of 6% to 8% . West pharmaceutical services inc- sales growth of high-value products is expected to be in low-double digits for fy 2017 . West pharmaceutical- s reaffirming its 2020 financial targets of sales between $2.2 billion-$2.4 billion with a consolidated operating profit margin in range 19%-23% . Fy2016 earnings per share view $2.21 -- Thomson Reuters I/B/E/S . Fy2016 revenue view $1.51 billion -- Thomson Reuters I/B/E/S .Fy2017 revenue view $1.63 billion -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-West Announces Board Approved Q4 Dividend Of $0.15/Share

* WEST ANNOUNCES THIRD-QUARTER DIVIDEND, INCREASE TO FOURTH-QUARTER DIVIDEND AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES